Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.69M Hold
30,000
– – 0.51% 46
2026
Q2
$1.69M Sell
30,000
-5,000
-14% -$279K 0.45% 41
2026
Q1
$2M Sell
35,000
-5,000
-13% -$284K 0.96% 31
2025
Q4
$2.13M Hold
40,000
– – 0.76% 33
2025
Q3
$2M Hold
40,000
– – 0.73% 35
2025
Q2
$2.06M Hold
40,000
– – 0.82% 35
2025
Q1
$2.14M Hold
40,000
– – 1.1% 26
2024
Q4
$1.91M Hold
40,000
– – 0.78% 33
2024
Q3
$1.78M Hold
40,000
– – 0.77% 35
2024
Q2
$1.7M Hold
40,000
– – 0.7% 36
2024
Q1
$1.66M Hold
40,000
– – 0.73% 40
2023
Q4
$1.47M Hold
40,000
– – 0.81% 34
2023
Q3
$1.42M Hold
40,000
– – 0.94% 32
2023
Q2
$1.36M Hold
40,000
– – 0.89% 36
2023
Q1
$1.38M Hold
40,000
– – 1.18% 33
2022
Q4
$1.31M Hold
40,000
– – 1.24% 28
2022
Q3
$1.2M Hold
40,000
– – 1.37% 25
2022
Q2
$1.17M Hold
40,000
– – 1.15% 29
2022
Q1
$1.33M Buy
+40,000
New +$1.29M 0.82% 36
2021
Q4
– Sell
-40,000
Closed -$1.14M – 105
2021
Q3
$1.14M Buy
+40,000
New +$1.13M 0.54% 44

Other funds holding MPLX

Geneva Partners's MPLX Position: Q3 2026 in Review

Geneva Partners held its MPLX (MPLX) position steady in Q3 2026 at 30,000 shares worth $1.69M. The position accounts for 0.51% of the portfolio, ranked #46.

Geneva Partners first reported a position in MPLX in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.14M in Q1 2025. 339 funds tracked by Wall St. Rank hold MPLX as of Q3 2026.

  • Geneva Partners held 30,000 shares of MPLX worth $1.69M as of Q3 2026.
  • Geneva Partners left its MPLX share count unchanged in Q3 2026.
  • MPLX made up 0.51% of Geneva Partners's portfolio in Q3 2026, its #46 holding.
  • Geneva Partners first reported a position in MPLX in Q3 2021 and has held it in 20 quarters since.
  • Geneva Partners's MPLX position peaked at $2.14M in Q1 2025.
  • 339 funds tracked by Wall St. Rank held MPLX as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.